{
  "docId": "019de076-4eee-72eb-9f75-bef42550a1c1",
  "docSlug": "3c2d586ebe2940705b3e5004470d76e3",
  "documentTitle": "Kymera | Investor Presentation Deck | 41 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 41,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "appendix_methodology",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Includes clinical trial identifiers and definitions of acronyms in the footer.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/20",
  "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1",
  "deckJsonHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1.json",
  "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "list",
      "text": "ZEN (HS) vs ADVANTA (AD) trial parameters including design, enrollment, duration, and outcome measures.",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b0cc654-9a90-4bc4-a6ae-5060087cbe73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Additional information on the Phase 2 studies can be found at www.clinicaltrials.gov; identifier NCT06028230 (HS) and NCT06058156 (AD); Study Sponsor: Sanofi",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8293b4b-3522-4408-9628-b6f98b5eb90f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "HiSCR50: Hidradenitis Suppurativa Clinical Response 50 | IHS4: International Hidradenitis Suppurativa Severity Score System | HS-Skin Pain-NRS: HS-Skin Pain-Numerical Rating Scale EASI: The Eczema Area and Severity Index; vIGA-AD: validated Investigational Global Assessment; PP-NRS: Peak Pruritus Numeric Rating Scale",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15b382d5-2c7b-4356-91c5-c7ec98cb82b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.05
      },
      "kind": "title",
      "text": "KT-474/SAR444656: Ongoing Phase 2 Trials in HS and AD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac85d9c8-ed2e-4aaf-b3da-74a4b3b0f50c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}